Literature DB >> 6275440

Relationship between plasma delta-9-tetrahydrocannabinol concentration and pharmacologic effects in man.

D M Cocchetto, S M Owens, M Perez-Reyes, S DiGuiseppi, L L Miller.   

Abstract

The relationship between each of two pharmacologic effects (tachycardia and psychological "high") of delta-9-tetrahydrocannabinol (THC) and plasma THC concentration was investigated in three male and three female experienced marihuana smokers. Each subject smoked 1% THC cigarette on two occasions separated by 2 h. Heart rate and subjective psychological self-rating were determined frequently throughout the 4 h study period. Data were analyzed by calculating the area under the parameter versus time curves, constructing hysteresis plots, and calculating the decay rate constants from pharmacologic effect versus time plots. In both males and females, dose inhaled and psychological response were apparently equivalent for the first and second cigarettes. While all subjects exhibited marked tachycardia in response to the first cigarette, heart rate in both male and female subjects was not increased as markedly during the second cigarette. Interestingly, female subjects had less tachycardiac response than males during the second cigarette. Hysteresis plots revealed that both heart rate and subjective psychological effect were elicited in an effect compartment which was "deep" relative to the reference plasma compartment. The time courses of tachycardiac and psychological responses lagged behind the plasma THC concentration-time profile. Zero-order decay rate constants for subjective psychological rating did not change substantially from the first to second cigarette. This study suggest that plasma THC concentration is a poor predictor of simultaneously occurring physiological and psychological pharmacologic effects.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275440     DOI: 10.1007/bf00432179

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Comparative bioavailabilities from truncated blood level curves.

Authors:  E G Lovering; I J McGilveray; I McMillan; W Tostowaryk
Journal:  J Pharm Sci       Date:  1975-09       Impact factor: 3.534

2.  Response optimization of drug dosage: antiarrhythmic studies with tocainide.

Authors:  P J Meffin; R A Winkle; T F Blaschke; J Fitzgerald; D C Harrison; S R Harapat; P A Bell
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

3.  Tolerance to marijuana: heart rate and subjective "high".

Authors:  R Nowlan; S Cohen
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

Review 4.  The pharmacokinetic bases of biological response quantification in toxicology, pharmacology and pharmacodynamics.

Authors:  E R Garrett
Journal:  Prog Drug Res       Date:  1977

5.  Pharmacokinetics of digoxin: relationship between response intensity and predicted compartmental drug levels in man.

Authors:  W G Kramer; A J Kolibash; R P Lewis; M S Bathala; J A Visconti; R H Reuning
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

6.  Some cardiovascular effects of marihuana smoking in normal volunteers.

Authors:  S Johnson; E F Domino
Journal:  Clin Pharmacol Ther       Date:  1971 Sep-Oct       Impact factor: 6.875

7.  A mathematical model for the pharmacokinetics of LSD effect.

Authors:  C M Metzler
Journal:  Clin Pharmacol Ther       Date:  1969 Sep-Oct       Impact factor: 6.875

8.  Dose-response analysis of the effects of tetrahydrocannabinol in man.

Authors:  G F Kiplinger; J E Manno; B E Rodda; R B Forney
Journal:  Clin Pharmacol Ther       Date:  1971 Jul-Aug       Impact factor: 6.875

9.  Modeling of drug response in individual subjects.

Authors:  A W Kelman; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1980-04

10.  Marijuana: dose-response effects on pulse rate, subjective estimates of potency, pleasantness, and recognition memory.

Authors:  L Miller; T Cornett; W Drew; D McFarland; D Brightwell; A Wikler
Journal:  Pharmacology       Date:  1977       Impact factor: 2.547

View more
  19 in total

1.  Population pharmacokinetic model of THC integrates oral, intravenous, and pulmonary dosing and characterizes short- and long-term pharmacokinetics.

Authors:  Jules A A C Heuberger; Zheng Guan; Olubukayo-Opeyemi Oyetayo; Linda Klumpers; Paul D Morrison; Tim L Beumer; Joop M A van Gerven; Adam F Cohen; Jan Freijer
Journal:  Clin Pharmacokinet       Date:  2015-02       Impact factor: 6.447

2.  Acute marijuana effects on social conversation.

Authors:  S T Higgins; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood.

Authors:  Margaret Haney; Judith Rabkin; Erik Gunderson; Richard W Foltin
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

4.  Relationships between several pharmacokinetic parameters and psychometric indices of subjective effects of delta 9-tetrahydrocannabinol in man.

Authors:  L L Miller; D M Cocchetto; M Perez-Reyes
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance.

Authors:  L D Chait; J L Perry
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

Review 6.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.

Authors:  Mehrak Javadi-Paydar; Jacques D Nguyen; Tony M Kerr; Yanabel Grant; Sophia A Vandewater; Maury Cole; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2018-06-16       Impact factor: 4.530

8.  Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use.

Authors:  J H Mendelson; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling.

Authors:  Zheng Liu; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2018-06-07       Impact factor: 4.335

Review 10.  The effect of cannabis compared with alcohol on driving.

Authors:  R Andrew Sewell; James Poling; Mehmet Sofuoglu
Journal:  Am J Addict       Date:  2009 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.